About 60% of GLP-1 users who experience gastrointestinal side effects report that nighttime injection significantly reduces their perception of nausea, simply because they sleep through the worst of it
Some people report weight changes with lower doses, but results vary
Currently, the single-agonist segment holds the maximum share of the GLP-1 market
No, the weight loss patches currently on the market dont contain GLP-1 or any of the active ingredients found in prescription treatments like Ozempic, Wegovy, or Mounjaro
Centers for Medicare & Medicaid Services new Patient Safety Structural Measure links PSO participation to reimbursement and transparency, prompting many hospitals to re-evaluate their safety strategy
Amy Nunn, executive director of the Rhode Island Public Health Institute and a professor at Brown Universitys School of Public Health